TMEM68 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.89750470680883E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.37280245136185E-11 |
Normal-vs-Stage2 |
8.73189999972546E-07 |
Normal-vs-Stage3 |
1.02579944538661E-10 |
Normal-vs-Stage4 |
3.53419515874975E-11 |
Stage1-vs-Stage2 |
1.322390E-01 |
Stage1-vs-Stage3 |
4.757600E-01 |
Stage1-vs-Stage4 |
3.902600E-01 |
Stage2-vs-Stage3 |
8.893800E-02 |
Stage2-vs-Stage4 |
6.194300E-02 |
Stage3-vs-Stage4 |
9.994800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.04010175209169E-11 |
Normal-vs-AfricanAmerican |
5.30520072317131E-11 |
Normal-vs-Asian |
2.149800E-02 |
Caucasian-vs-AfricanAmerican |
4.479600E-01 |
Caucasian-vs-Asian |
7.796600E-01 |
AfricanAmerican-vs-Asian |
5.325800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.63099550426682E-11 |
Normal-vs-Female |
3.24750004665475E-10 |
Male-vs-Female |
3.184600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.40529834833114E-11 |
Normal-vs-Age(41-60Yrs) |
9.50050038639461E-11 |
Normal-vs-Age(61-80Yrs) |
9.99510474386511E-11 |
Normal-vs-Age(81-100Yrs) |
9.07110000003541E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.725230E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.842580E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.053800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.715000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.626000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.710400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.43339999997872E-07 |
Normal-vs-Grade 2 |
1.60199997711885E-09 |
Normal-vs-Grade 3 |
1.520894521434E-11 |
Normal-vs-Grade 4 |
2.44715359087877E-12 |
Grade 1-vs-Grade 2 |
7.492400E-01 |
Grade 1-vs-Grade 3 |
2.502200E-01 |
Grade 1-vs-Grade 4 |
5.482500E-02 |
Grade 2-vs-Grade 3 |
3.279700E-02 |
Grade 2-vs-Grade 4 |
1.681060E-03 |
Grade 3-vs-Grade 4 |
1.162360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.88320051061919E-10 |
Normal-vs-ccB subtype |
1.94639970807486E-10 |
ccA subtype-vs-ccB subtype |
4.912000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.01039979003315E-10 |
Normal-vs-N1 |
1.17590000003887E-06 |
N0-vs-N1 |
6.449400E-01 |
|
|